191 related articles for article (PubMed ID: 27828785)
1. Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants.
Shiau S; Strehlau R; Technau KG; Patel F; Arpadi SM; Coovadia A; Abrams EJ; Kuhn L
AIDS; 2017 Jan; 31(3):355-364. PubMed ID: 27828785
[TBL] [Abstract][Full Text] [Related]
2. Early antiretroviral therapy in HIV-infected infants: can it lead to HIV remission?
Shiau S; Abrams EJ; Arpadi SM; Kuhn L
Lancet HIV; 2018 May; 5(5):e250-e258. PubMed ID: 29739699
[TBL] [Abstract][Full Text] [Related]
3. Rapid decline of HIV-1 DNA and RNA in infants starting very early antiretroviral therapy may pose a diagnostic challenge.
Veldsman KA; Maritz J; Isaacs S; Katusiime MG; Janse van Rensburg A; Laughton B; Mellors JW; Cotton MF; van Zyl GU
AIDS; 2018 Mar; 32(5):629-634. PubMed ID: 29334551
[TBL] [Abstract][Full Text] [Related]
4. Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children.
Ásbjörnsdóttir KH; Hughes JP; Wamalwa D; Langat A; Slyker JA; Okinyi HM; Overbaugh J; Benki-Nugent S; Tapia K; Maleche-Obimbo E; Rowhani-Rahbar A; John-Stewart G
AIDS; 2016 Nov; 30(18):2835-2843. PubMed ID: 27603293
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of early initiated antiretroviral therapy in sub-Saharan children: a Cameroonian cohort study (ANRS-12140 Pediacam study, 2008-2013, Cameroon).
Ndongo FA; Tejiokem MC; Penda CI; Ndiang ST; Ndongo JA; Guemkam G; Sofeu CL; Tagnouokam-Ngoupo PA; Kfutwah A; Msellati P; Faye A; Warszawski J
BMC Pediatr; 2021 Apr; 21(1):189. PubMed ID: 33882903
[TBL] [Abstract][Full Text] [Related]
6. Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed.
Kuhn L; Schramm DB; Shiau S; Strehlau R; Pinillos F; Technau K; Coovadia A; Abrams EJ; Puren A; Tiemessen CT
AIDS; 2015 Jun; 29(9):1053-60. PubMed ID: 25870988
[TBL] [Abstract][Full Text] [Related]
7. Virologic Response to Early Antiretroviral Therapy in HIV-infected Infants: Evaluation After 2 Years of Treatment in the Pediacam Study, Cameroon.
Ateba Ndongo F; Texier G; Ida Penda C; Tejiokem MC; Tetang Ndiang S; Ndongo JA; Guemkam G; Sofeu CL; Kfutwah A; Faye A; Msellati P; Warszawski J;
Pediatr Infect Dis J; 2018 Jan; 37(1):78-84. PubMed ID: 28841582
[TBL] [Abstract][Full Text] [Related]
8. 12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study.
Technau KG; Strehlau R; Patel F; Shiau S; Burke M; Conradie M; Sorour G; Sherman GG; Coovadia A; Murnane PM; Abrams EJ; Kuhn L
Lancet HIV; 2018 Dec; 5(12):e706-e714. PubMed ID: 30416043
[TBL] [Abstract][Full Text] [Related]
9. Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study.
O'Connor J; Smith C; Lampe FC; Johnson MA; Chadwick DR; Nelson M; Dunn D; Winston A; Post FA; Sabin C; Phillips AN;
Lancet HIV; 2017 Jul; 4(7):e295-e302. PubMed ID: 28479492
[TBL] [Abstract][Full Text] [Related]
10. Optimization of antiretroviral therapy in HIV-infected children under 3 years of age: a systematic review.
Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams EJ
AIDS; 2014 Mar; 28 Suppl 2():S137-46. PubMed ID: 24849473
[TBL] [Abstract][Full Text] [Related]
11. Virologic outcomes in early antiretroviral treatment: HPTN 052.
Eshleman SH; Wilson EA; Zhang XC; Ou SS; Piwowar-Manning E; Eron JJ; McCauley M; Gamble T; Gallant JE; Hosseinipour MC; Kumarasamy N; Hakim JG; Kalonga B; Pilotto JH; Grinsztejn B; Godbole SV; Chotirosniramit N; Santos BR; Shava E; Mills LA; Panchia R; Mwelase N; Mayer KH; Chen YQ; Cohen MS; Fogel JM
HIV Clin Trials; 2017 May; 18(3):100-109. PubMed ID: 28385131
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
13. Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis.
Reitz C; Coovadia A; Ko S; Meyers T; Strehlau R; Sherman G; Kuhn L; Abrams EJ
J Infect Dis; 2010 Apr; 201(8):1121-31. PubMed ID: 20214476
[TBL] [Abstract][Full Text] [Related]
14. Early antiretroviral therapy reduces HIV DNA following perinatal HIV infection.
Foster C; Pace M; Kaye S; Hopkins E; Jones M; Robinson N; Mant C; Cason J; Fidler S; Frater J;
AIDS; 2017 Aug; 31(13):1847-1851. PubMed ID: 28609403
[TBL] [Abstract][Full Text] [Related]
15. Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus.
Shiau S; Arpadi S; Strehlau R; Martens L; Patel F; Coovadia A; Abrams EJ; Kuhn L
J Pediatr; 2013 Jun; 162(6):1138-45, 1145.e1-2. PubMed ID: 23312691
[TBL] [Abstract][Full Text] [Related]
16. Virologic failure is uncommon after treatment initiation during acute HIV infection.
Crowell TA; Phanuphak N; Pinyakorn S; Kroon E; Fletcher JL; Colby D; Tipsuk S; Karnsomlap P; Laopraynak N; O'Connell RJ; Robb ML; Ananworanich J;
AIDS; 2016 Jul; 30(12):1943-50. PubMed ID: 27163706
[TBL] [Abstract][Full Text] [Related]
17. Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children.
Kuhn L; Paximadis M; Da Costa Dias B; Loubser S; Strehlau R; Patel F; Shiau S; Coovadia A; Abrams EJ; Tiemessen CT
PLoS One; 2018; 13(4):e0195514. PubMed ID: 29649264
[TBL] [Abstract][Full Text] [Related]
18. Nevirapine Resistance in Previously Nevirapine-Unexposed HIV-1-Infected Kenyan Infants Initiating Early Antiretroviral Therapy.
Chohan BH; Tapia K; Benki-Nugent S; Khasimwa B; Ngayo M; Maleche-Obimbo E; Wamalwa D; Overbaugh J; John-Stewart G
AIDS Res Hum Retroviruses; 2015 Aug; 31(8):783-91. PubMed ID: 25819584
[TBL] [Abstract][Full Text] [Related]
19. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships.
Mujugira A; Celum C; Tappero JW; Ronald A; Mugo N; Baeten JM
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):148-54. PubMed ID: 26670218
[TBL] [Abstract][Full Text] [Related]
20. CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era.
Roul H; Mary-Krause M; Ghosn J; Delaugerre C; Pialoux G; Cuzin L; Launay O; Lacombe JM; Menard A; De Truchis P; Delfraissy JF; Weiss L; Costagliola D;
AIDS; 2018 Nov; 32(17):2605-2614. PubMed ID: 30289817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
